Table 2.
Evalution of rebleeding according to the demographic data n (%)
|
Rebleeding |
P | |||
| (+) | (-) | |||
| Age, n (%) | < 70 yr | 32 (32) | 68 (68) | 10.001b |
| > 70 yr | 24 (61.5) | 15 (38.5) | ||
| Comorbidity | 33 (66) | 17 (34) | 20.001b | |
| OGIB | ||||
| Overt | 42 (48.8) | 44 (51.2) | 20.015a | |
| Occult | 14 (26.4) | 39 (73.6) | ||
| Vasculary lesion | 31 (72.1) | 12 (27.9) | 20.001b | |
| Positive capsule result | 55 (46.6) | 63 (53.4) | 20.001b | |
| NSAIDs-anticoagulant antiaggregant therapy | 19 (73.1) | 7 (26.9) | 20.001b | |
1
Pearson Ki-kare test;
2
Yates’ Continuity Correction test.
a
P < 0.05;
b
P < 0.01. OGIB: Obscure gastrointestinal bleeding; NSAIDs: Non-steroidal anti-inflammatory drugs.